ChomTech Secures Medical Device Manufacturing License, Clearing Final Hurdle for Global-First Nystagmus Therapy

This successful approval is a concrete manifestation of the Beijing Medical Device Review and Inspection Center and the Fourth Branch of the Beijing Drug Administration advancing the reform of the review and approval system to promote the rapid market entry of innovative products. During the product’s market entry process, the Beijing Drug Administration initiated an innovative service mechanism, ensuring the swift progress of this globally pioneering product’s transformation, demonstrating its responsibility and commitment in promoting the high-quality development of the pharmaceutical and health industry.

With the smooth acquisition of the production license,Super Vision Technology, Inc. to Launch Scale Production and Market Promotion of i-NYS Implantable Ocular Muscle Neurostimulator。As the world's first medical device specifically designed to treat congenital nystagmus, this product will officially move from the research and development stage into clinical application, providing a new treatment option for relevant patient groups.